Novartis Ag (NVSEF) Total Liabilities (2009 - 2025)

Novartis Ag has disclosed Total Liabilities across 13 years of filings, most recently posting $64.4 billion for Q4 2025.

• Total Liabilities for Q4 2025 came in at $64.4 billion, up 10.81% year-over-year; the trailing twelve-month figure through Dec 2025 was $64.4 billion (up 10.81% YoY), and the FY2025 annual result was $64.4 billion, up 10.81% from the prior year.
• Total Liabilities came in at $64.4 billion for Q4 2025 at Novartis Ag, up from $62.3 billion in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $69.9 billion in Q2 2021 to a low of $53.2 billion in Q4 2023.
• The 5-year median for Total Liabilities is $59.5 billion (2022), against an average of $60.5 billion.
• Across the five-year window, Total Liabilities fell 14.28% in 2022 and advanced 12.12% in 2025, its largest moves.
• Novartis Ag's Total Liabilities stood at $64.0 billion in 2021, then declined by 9.29% to $58.0 billion in 2022, then slipped by 8.33% to $53.2 billion in 2023, then advanced by 9.26% to $58.1 billion in 2024, then rose by 10.81% to $64.4 billion in 2025.
• The last three Total Liabilities figures came in at $64.4 billion (Q4 2025), $62.3 billion (Q2 2025), and $58.1 billion (Q4 2024), per Business Quant data.